Skip to main content
Log in

Non-nephrotic children with membranoproliferative glomerulonephritis: are steroids indicated?

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Alternate-day steroids are currently recommended to treat children with membranoproliferative glomerulonephritis (MPGN). This recommendation is based largely on uncontrolled studies demonstrating improved renal survival with steroid therapy. We reviewed the outcome of 39 children who presented with MPGN between 1968 and 1990; 27 children were treated with steroids and 12 children received no drug therapy. Life-table analysis comparing renal survival of treated versus untreated children demonstrated no difference by log rank analysis. Treated and untreated groups were compared on the basis of nine features at presentation: age, sex, type of MPGN, presence and type of hematuria, hypocomplementemia, renal insufficiency, hypertension, and nephrosis. Treated children were likely to be female (P<0.01) and nephrotic (P<0.02). Actuarial survival analyses were performed comparing the nine features with renal survival through 10 years of follow-up. Normotensive (P<0.025) and non-nephrotic (P<0.05) children had improved renal survival. The 11 non-nephrotic children demonstrated 100% long-term renal survival, including 7 who received no steroid therapy. At last follow-up, all non-nephrotic children had normal renal function, serum albumin levels >3 g/dl, and were normotensive. These data suggest that non-nephrotic children with MPGN may forego steroid treatment without compromising long-term renal function. The current common practice of treating all children with MPGN with steroids should be re-examined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. West C (1992) Idiopathic membranoproliferative glomerulonephritis in childhood. Pediatr Nephrol 6: 96–103

    Google Scholar 

  2. Strife CF, McAdams AJ, West CD (1982) Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions. Clin Nephrol 18: 9–16

    Google Scholar 

  3. Robson AM, Cole BR, Kienstra RA, Kissane JM, Alkjaersig N, Fletcher AP (1977) Severe glomerulonephritis complicated by coagulopathy: treatment with anticoagulant and immunosuppressive drugs. J Pediatr 90: 881–892

    Google Scholar 

  4. Chapman SJ, Cameron JS, Chantler C, Turner D (1980) Treatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation. Arch Dis Child 55: 446–451

    Google Scholar 

  5. Donadio JV, Anderson CF, Mitchell JC III, Holley KE, Ilstrup DM, Fuster V, Chesebro JH (1984) Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet inhibitor therapy. N Engl J Med 310: 1421–1426

    Google Scholar 

  6. Holland NH, Bennett NM (1972) Hypocomplementemic (membrano-proliferative) glomerulonephritis. Immunosuppressive therapy. Am J Dis Child 123: 439–445

    Google Scholar 

  7. Cameron JS, Glasgow EF, Ogg CS, White RHR (1970) Membranoproliferative glomerulonephritis and persistent hypocomplementemia. BMJ 4: 7–14

    Google Scholar 

  8. Schmitt H, Bohle A, Reineke T, Mayer-Echberger D, Vogl W (1990) Long-term prognosis of membranoproliferative glomerulonephritis type I. Nephron 55: 242–250

    Google Scholar 

  9. McAdams AJ, McEnery PT, West CD (1975) Mesangiocapillary glomerulonephritis: changes in glomerular morphology with longterm alternate day prednisone therapy. J Pediatr 86: 23–31

    Google Scholar 

  10. McEnery PT, McAdams AJ, West CD (1980) Membranoproliferative glomerulonephritis. Improved survival with alternate day prednisone therapy. Clin Nephrol 13: 117–124

    Google Scholar 

  11. Warady BA, Gugenheim SJ, Sedman A, Lum GM (1985) Prednisone therapy of membranoproliferative glomerulonephritis in children. J Pediatr 107: 702–707

    Google Scholar 

  12. Mota-Hernandez F, Gordillo-Paniagua G, Munoz-Arizpe R, Lopez-Arriaga JA, Barboza-Madueno L (1985) Prednisone versus placebo in membranoproliferative glomerulonephritis: long-term clinicopathological correlations. Int J Pediatr Nephrol 6: 25–28

    Google Scholar 

  13. Ford DM, Briscoe DM, Shanley PF, Lum G (1990) Childhood membranoproliferative glomerulonephritis type I: limited steroid therapy. Kidney Int 116: S109-S114

    Google Scholar 

  14. West CD (1986) Childhood membranoproliferative glomerulonephritis: an approach to management. Kidney Int 29: 1077–1093

    Google Scholar 

  15. McEnery PT (1990) Membranoproliferative glomerulonephritis: the Cincinnati experience—cumulative renal survival from 1957 to 1989. J. Pediatr 116: S109-S114

    Google Scholar 

  16. Davis AE III, Schneeberger EE, Grupe WE, McCluskey RT (1978) Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease (DDD) in children. Clin Nephrol 9: 184–193

    Google Scholar 

  17. Habib R, Kleinknecht C, Gubler M-C, Levy M (1973) Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases. Clin Nephrol 4: 194–214

    Google Scholar 

  18. A Report of the International Study of Kidney Disease in Children (1982) Alternate-day steroid therapy in membranoproliferative glomerulonephritis: a randomized controlled clinical trial (abstract). Kidney Int 21: 150

    Google Scholar 

  19. McEnery PT, McAdams AJ, West CD (1986) The effect of prednisone in a high-dose, alternate day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis. Medicine (Baltimore) 64: 401–424

    Google Scholar 

  20. Cameron JS, Turner DR, Heaton J, Williams DG, Ogg CS, Chantler C, Haycock GB, Hicks J (1983) Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am J Med 74: 175–192

    Google Scholar 

  21. Cameron JS, Ogg CS, White RHR, Glasgow EF (1973) The clinical features and prognosis of patients with normocomplementemic mesangiocapillary glomerulonephritis. Clin Nephrol 1: 8–13

    Google Scholar 

  22. Churg J, Habib R, White RHR (1970) Pathology of the nephrotic syndrome in children. A report for the International Study of Kidney Disease in Children. Lancet 1: 1299–1302

    Google Scholar 

  23. Churg J, Sobin LH (1982) Diffuse mesangiocapillary glomerulonephritis. In: Churg J, Sobin LH (eds) Renal disease. Classification and atlas of glomerular diseases. Igaku-Shoin, Tokyo, p 83

    Google Scholar 

  24. Schwartz GJ, Haycock GB, Edelmann CM (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259–263

    Google Scholar 

  25. Ginsberg JM, Chang BS, Matarese RA, Garella S (1983) Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309: 1543–1546

    Google Scholar 

  26. Houser M (1984) Assessment of proteinuria using random urine samples. J Pediatr 104: 845–848

    Google Scholar 

  27. Shaw AB, Risdon P, Lewis-Jackson JP (1983) Protein, creatinine and Albustix in assessment of proteinuria. BMJ 287: 929–932

    Google Scholar 

  28. Task Force on Blood Pressure Control in Children (1987) Report of the second task force on blood pressure control in children-1987. Pediatrics 79: 1–25

    Google Scholar 

  29. Cutler SJ, Ederer F (1958) Maximum utilization of the life table method in analyzing survival. J Chron Dis 8: 699

    Google Scholar 

  30. Peto R, Pike C, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 35: 1–39

    Google Scholar 

  31. Habib R, Gubler MC, Loirat C, Maiz HB, Levy M (1975) Dense deposit disease: a variant of membranoproliferative glomerulonephritis. Kidney Int 7: 204–215

    Google Scholar 

  32. Watson AR, Poucell S, Thorner P, Arbus GS, Rance CP, Baumal R (1984) Membranoproliferative glomerulonephritis type I in children: correlation of clinical features with pathologic subtypes. Am J Kidney Dis 4: 141–146

    Google Scholar 

  33. McEnery PT, Poutinho M-J (1994) Membranoproliferative glomerulonephritis. In: Holliday MA, Barratt TM, Avner ED (eds) Pediatric nephrology, 3rd edn. Williams and Wilkins, Baltimore, pp 739–753

    Google Scholar 

  34. Coutinho M, McEnery PT (1992) Membranoproliferative glomerulonephritis (MPGN)—experience with discontinuation of prednisone therapy and identification of factors correlating with outcome (abstract). J Am Soc Nephrol 3: 309

    Google Scholar 

  35. Tarshish P, Bernstein J, Tobin JN, Edelmann CM Jr (1992) Treatment of mesangiocapillary glomerulonephritis with alternate day prednisone—a report of the International Study of Kidney Disease in Children. Pediatr Nephrol 6: 123–130

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Somers, M., Kertesz, S., Rosen, S. et al. Non-nephrotic children with membranoproliferative glomerulonephritis: are steroids indicated?. Pediatr Nephrol 9, 140–144 (1995). https://doi.org/10.1007/BF00860727

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00860727

Key words

Navigation